Loading clinical trials...
Loading clinical trials...
The primary objective of this study is to build a well characterized cohort of patients that will be used to determine the genetic variants associated with obstructive sleep apnea (OSA)and its co-morbidities.
The purpose of building the cohort is to allow the performance of genome-wide association studies with a large sample of patients that have been well-characterized using standardized procedures.
Age
18 - 70 years
Sex
ALL
Healthy Volunteers
No
Suite 2600, Martha Morehouse Medical Pavilion
Columbus, Ohio, United States
Start Date
August 1, 2012
Primary Completion Date
December 1, 2025
Completion Date
December 1, 2025
Last Updated
July 24, 2025
5,000
ESTIMATED participants
Lead Sponsor
Ulysses Magalang MD
NCT06430957
NCT07292922
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT07225686